dc.contributorUniversidade Federal da Bahia (UFBA)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T15:26:49Z
dc.date.accessioned2022-10-05T16:39:45Z
dc.date.available2014-05-20T15:26:49Z
dc.date.available2022-10-05T16:39:45Z
dc.date.created2014-05-20T15:26:49Z
dc.date.issued2001-01-01
dc.identifierActa Cytologica. St Louis: Sci Printers & Publ Inc., v. 45, n. 1, p. 18-22, 2001.
dc.identifier0001-5547
dc.identifierhttp://hdl.handle.net/11449/36899
dc.identifier10.1159/000327182
dc.identifierWOS:000166823800004
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3908523
dc.description.abstractOBJECTIVE: To analyze the role of immunochemistry in serous effusions.STUDY DESIGN: We analyzed cell blocks of 18 pleural and 18 peritoneal effusions diagnosed as malignant (18), benign (14) and suspicious (4). They were immunostained by the avidin-biotin complex method with a panel of four monoclonal antibodies-CEA, Ber-EP4, LeuM1 (CD15) and r53-and for lectins (Ulex europaeus) UEA-1, ConA and ConBr. RESULTS: Seventeen of the 18 cases of adenocarcinoma were positive for CEA (95%), 12 (66.6%)for Bev-EP4, 11 (61 %)for CD15 nild 11 (62 %)for p53. Twelve of the 18 (66.6%) were positive for UEA-1, CEA, Ber-EP4 and CD15. UEA-1 did not react with mesothelial cells. p53 Gave a positive reaction in only one case, reactive mesothelial cells. ConA and ConBr reacted indiscriminately with benign and malignant cells; thus, it was not useful in distinguishing between these cells.CONCLUSION: In this context no antibody used alone is reliable for corroborating a diagnosis, but the selective use of a small panel of three markers (CEA, Ber-EP4 and LeuM1) can be very useful in solving diagnostic difficulties in the cytodiagnosis of serous effusions.
dc.languageeng
dc.publisherSci Printers & Publ Inc
dc.relationActa Cytologica
dc.relation0,480
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectcells
dc.subjectneoplasms
dc.subjectimmunocytochemistry
dc.subjectserous effusions
dc.titleCharacterizing subpopulations of neoplastic cells in serous effusions - the role of immunocytochemistry
dc.typeArtigo


Este ítem pertenece a la siguiente institución